Lumos Diagnostics announced that Jerome Adams, MD, MPH, will serve as a Strategic Healthcare Adviser to Lumos and will be appointed to the company's Medical Advisory Board. From 2017 to 2021, Dr. Adams served as the 20th Surgeon General of the United States. As the immediate former U.S. Surgeon General, Dr. Adams brings a real-world public health perspective to the ongoing impact of global issues such as antimicrobial resistance and COVID-19. Utilizing his robust knowledge of public health, public policy and health equity, Dr. Adams will advise Lumos on the effective deployment of its POC diagnostic technologies, beginning with the launch of the FebriDx® test in approved markets. FebriDx is a novel fingerstick blood test that can differentiate if a person has a bacterial or viral infection, which often have overlapping signs and symptoms, within 10 minutes.